Figure 1
![Figure 1. Biodistributions of [213Bi]DOTA-biotin in tumor, blood, and normal organs after PRIT with 1F5-SA or CC49-SA FPs. Athymic mice bearing Ramos xenografts were injected with 2.8nM each unlabeled FP followed 20 hours later by 5.8nM CA, and 4 hours after that by 1.2nM [213Bi]DOTA-biotin. Groups of 5 mice were euthanized 10, 45, 90, and 180 minutes after the injection of [213Bi]DOTA-biotin. The radioactivity in the tissues were quantified by gamma counting, corrected for decay, and expressed as the % ID/g of tissue.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/116/20/10.1182_blood-2010-05-282327/7/zh89991060470001.jpeg?Expires=1735847371&Signature=drs2JjbmqoZFYHPUtdjHkLcPdFG2lsXweOCojDJw5h7re4OWqs9nwNTn7mWNCPDSu4KgGt8S~CBDF0oXeMOMPqTsCdhK0nz7W1R86TUhTQg4n09UqhNd4-xnY5vY2rPY2VIjdTZzSPsFQupCxF5LZFsb8TG2rGiPIA~Q8DmL0rmWESHk2iuYKaqzSIWeIsnN6bd9~HSrBh4jUeA3Aqwv6kUyPF601xzXjvm1HM2M67tYzhbkhz1VXWcZkOpcBF~rOqrVzKsIaoPUqIi-wNVrjwL0H3gOAHWsOZCKgVralDOGoHIRAyhddbA1329T7zE2Xg2rSY-AUDsGq9yo6V5-Gg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Biodistributions of [213Bi]DOTA-biotin in tumor, blood, and normal organs after PRIT with 1F5-SA or CC49-SA FPs. Athymic mice bearing Ramos xenografts were injected with 2.8nM each unlabeled FP followed 20 hours later by 5.8nM CA, and 4 hours after that by 1.2nM [213Bi]DOTA-biotin. Groups of 5 mice were euthanized 10, 45, 90, and 180 minutes after the injection of [213Bi]DOTA-biotin. The radioactivity in the tissues were quantified by gamma counting, corrected for decay, and expressed as the % ID/g of tissue.
